title: Interferon alpha 2-b therapy of HCV and nonBnonC chronic hepatitis.
abstract: Twenty-four patients with HCV and NonBNonC chronic hepatitis--4 with HIV coinfection--were treated with r-IFN alpha for at least six months. In this period 62.5% of patients show a normalization of ALT but not a sustained remission. Non-responders have histologically more severe and long-lasting chronic hepatitis.
authors.affiliation: Sezione Malattie Infettive, Ospedale Civile G. Mazzini, Teramo, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Gargiulo
authors.forename: P
authors.initials: P
authors.lastname: Tarquini
authors.forename: L
authors.initials: L
authors.lastname: Di Ottavio
authors.forename: E
authors.initials: E
authors.lastname: Lattanzi
authors.forename: A
authors.initials: A
authors.lastname: De Nigris-Urbani
mesh_terms: D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D005260:Female; D006526:Hepatitis C / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000628:therapy*; D006525:Hepatitis, Viral, Human / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012074:Remission Induction
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D000410:Alanine Transaminase